This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Immunotech Biopharm Co., Ltd., National Institutes for Food and Drug Control, Pharos Vaccine Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 2 
1 out of 2 Years Active: 2025
Title: Hyunsoo Lee: Innovator in T-Cell Therapy
Introduction
Hyunsoo Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedicine, particularly in the area of T-cell therapy. His innovative approach aims to enhance cancer treatment efficacy through advanced therapeutic methods.
Latest Patents
Hyunsoo Lee holds a patent for a T-cell therapy method. This invention focuses on improving the effectiveness of therapeutic T cells, such as CAR-T or TCR-T cells. The method involves stimulating these cells with living cells that express cancer-related antigens, thereby enhancing their ability to combat cancer.
Career Highlights
Throughout his career, Hyunsoo Lee has worked with notable companies in the biopharmaceutical sector. He has been associated with Immunotech Biopharm Co., Ltd. and Pharos Vaccine Inc., where he has contributed to the development of innovative therapies.
Collaborations
Hyunsoo Lee has collaborated with talented individuals in his field, including Yu Wang and Namchul Jung. These partnerships have fostered a collaborative environment that promotes innovation and advancement in T-cell therapy.
Conclusion
Hyunsoo Lee's work in T-cell therapy represents a significant advancement in cancer treatment. His innovative methods and collaborations highlight his commitment to improving patient outcomes through biomedicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile